Second primary malignancies in patients with male breast cancer

British Journal of Cancer

Volumn 92, Issue 7, 2005, Pages 1288-1292

  Hemminki, K ^a,b   Scelo G ^c   Boffetta, P ^c   Mellemkjaer, L ^d   Tracey, E ^e   Andersen, A ^f   Brewster, D H ^g   Pukkala, E ^h   McBride, M ⁱ   Kliewer, E V ^j,k   Chia, K S ^l   Pompe Kirn, V ^m   Martos, C ⁿ   Jonasson, J G ^o,p   Li, X ^b   Brennan, P ^c  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b KAROLINSKA INSTITUTE   (Sweden)

^c INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^d INSTITUTE OF CANCER EPIDEMIOLOGY   (Denmark)

^e Central Cancer Registry   (Australia)

^f CANCER REGISTRY OF NORWAY   (Norway)

^g INFORMATION SERVICES DIVISION   (United Kingdom)

^h FINNISH CANCER REGISTRY   (Finland)

ⁱ Cancer Control Research   (Canada)

^j Epidemiology and Cancer Registry   (Canada)

^k UNIVERSITY OF MANITOBA   (Canada)

^l Singapore Cancer Registry   (Singapore)

^m INSTITUTE OF ONCOLOGY   (Slovenia)

ⁿ Cancer Registry of Zaragoza   (Spain)

^o ICELANDIC CANCER REGISTRY   (Iceland)

^p UNIVERSITY OF ICELAND   (Iceland)

more..

Author keywords

BRCA in men; Cancer registry; Discordant sites; Pooled analysis; Subsequent malignancy

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER INCIDENCE; CANCER LOCALIZATION; CANCER REGISTRY; CANCER RISK; CLINICAL TRIAL; CONFIDENCE INTERVAL; DISEASE ASSOCIATION; GENE MUTATION; HEMATOPOIETIC SYSTEM; HUMAN; HUMAN CELL; HUMAN TISSUE; INTERNATIONAL COOPERATION; MALE; MALE BREAST; MULTICENTER STUDY; PANCREAS CANCER; PRIORITY JOURNAL; PROSTATE CANCER; RECTUM CANCER; SECOND CANCER; SKIN CANCER; SMALL INTESTINE CANCER; STANDARDIZATION;

ADULT; AGED; BREAST NEOPLASMS, MALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEOPLASMS, SECOND PRIMARY; REGISTRIES; RISK FACTORS;

EID: 20944443183     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6602505     Document Type: Article

References (17)

1. Auvinen A, Curstis R, Ron E (2002) Risk of subsequent cancer following breast cancer in men. J Natl Cancer Inst 94: 1330-1332
2. Buzdar A (2003) Breast cancer in men. Oncology 17: 1361-1364
3. Chen Y, Thompson W, Semenciw R, Mao Y (1999) Epidemiology of contralateral breast cancer. Cancer Epidemiol Biomarkers Prev 8: 855-861
4. Dong C, Hemminki K (2001) Second primary breast cancer in men. Breast Cancer Res Treat 66: 171-172
5. Gennari R, Curigliano G, Jereczek-Fossa BA, Zurrida S, Renne G, Intra M, Galimberti V, Luini A, Orecchia R, Viale G, Goldhrisch A, Veronesi U (2004) Male breast cancer: a special therapeutic problem. Anything new? [review]. Int J Oncol 24: 663-670
6. Hemminki K, Granstrom C (2002) Re: Risk of subsequent cancer following breast cancer in men. J Natl Cancer Inst 94: 1892
7. Hemminki K, Jiang Y, Steineck G (2003a) Skin cancer and non-Hodgkin's lymphoma as second malignancies: markers of impaired immune function? Eur J Cancer 39: 223-229
8. Hemminki K, Li X (2001) Incidence trends and risk factors of carcinoid tumors. Cancer 92: 2204-2210
9. Hemminki K, Li X (2003) Level of education and the risk of cancer in Sweden. Cancer Epidemiol Biomarkers Prev 12: 796-802
10. Hemminki K, Zhang H, Czene K (2003b) Socioeconomic factors in cancer in Sweden. Int J Cancer 105: 692-700
11. Hsing AW, McLaughlin JK, Cocco P, Co Chien HT, Fraumeni Jr JF (1998) Risk factors for male breast cancer (United States). Cancer Causes Control 9: 269-275
12. Hultborn R, Hanson C, Kopf I, Verbiene I, Warnhammar E, Weimarck A (1997) Prevalence of Klienefelter's syndrome in male breast cancer patients. Anticancer Res 17: 4293-4297
13. Liede A, Karlan BY, Narod SA (2004) Cancer risks for male carriers of germline mutations in BRCA1 or BRCA2: a review of the literature. J Clin Oncol 22: 735-742
14. Lynch H, Watson P, Narod S (1999) The genetic epidemiology of male breast carcinoma. Cancer 86: 244-246
15. Muir C, Percy C (1991) Classification and coding of neoplasms. In Cancer Registration: Priciples and Methods Jensen O, Parkin D, MacLennan R, Muir C, Skeet R (eds) Vol. 95, pp 64-81. Lyon: IARC Science Publications
16. Swerdlow A, Barber J, Hudson G, Cunningham D, Gupta R, Hancock B, Horwich A, Lister T, Linch D (2000) Risk of second malignancy after Hodgkin's disease in a collaborative British cohort: the relation to age at treatment. J Clin Oncol 18: 498-509
17. Vaittinen P, Hemminki K (2000) Risk factors and age-incidence relationships for contralateral breast cancer. Int J Cancer 88: 998-1002